NEW YORK (GenomeWeb) – Cancer Genetics today announced a 24 percent jump in its third quarter revenues on strong performance in its biopharma services business.

For the three-month period ended Sept. 30, the Rutherford, New Jersey-based cancer diagnostics firm reported revenues of $4 million compared with $3.2 million in the same period last year, matching analysts' consensus estimate. Biopharma services revenues increased 35 percent to $2.6 million from $1.9 million, offsetting a $100,000 decline in clinical services revenue to $1.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.